68819-84-1

Basic information

• Product Name: TERT-BUTYL 4-BROMOBENZYLCARBAMATE
• Synonyms: TERT-BUTYL 4-BROMOBENZYLCARBAMATE;Carbamic acid, (4-bromophenyl)methyl-, 1,1-dimethylethyl ester;(4-BROMO-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER;N-BOC-4-broMobenzylaMine;4-Bromo-N-BOC-benzylamine;N-(4-Bromobenzyl)carbamic acid tert-butyl ester;tert-Butyl N-(4-bromobenzyl)carbamate;Carbamic acid, N-[(4-bromophenyl)methyl]-, 1,1-dimethylethyl ester
• CAS NO: 68819-84-1
• Molecular Formula: C₁₂H₁₆BrNO₂
• Molecular Weight: 286.16494
• Product Categories: amine|alkyl bromide| carboxylic ester
• Mol File: 68819-84-1.mol
• Article Data: 42

Chemical Properties

• Melting Point: 86-88℃
• Boiling Point: 370.3 °C at 760 mmHg
• Flash Point: 177.8 °C
• Appearance: /
• Density: 1.319 g/cm³
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 12.05±0.46(Predicted)
• Water Solubility: at 25 deg C (mg/L): 6.688
• CAS DataBase Reference: TERT-BUTYL 4-BROMOBENZYLCARBAMATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 4-BROMOBENZYLCARBAMATE(68819-84-1)
• EPA Substance Registry System: TERT-BUTYL 4-BROMOBENZYLCARBAMATE(68819-84-1)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 68819-84-1(Hazardous Substances Data)

Usage

General Description

Tert-Butyl 4-Bromobenzylcarbamate is a chemical compound which belongs to the class of organic compounds known as benzene and substituted derivatives. It is used primarily as an organic synthetic intermediate, especially in the pharmaceutical industry for the production of a variety of drugs. It is composed of structural molecules which include a carbamate group (organic functional group that is derived from carbonic acid) attached to a tert-butyl group and a benzene ring substituted with a bromine atom and benzyl group. The physical and chemical properties of this compound vary based on conditions such as temperature and pressure, and it must be handled with care due to its reactivity.

InChI:InChI=1S/C12H16BrNO2/c1-12(2,3)16-11(15)14-8-9-4-6-10(13)7-5-9/h4-7H,8H2,1-3H3,(H,14,15)

Upstream product

• 66389-77-3 methyl tert-butyl iminodicarboxylate potassium salt 
• 589-15-1 1-bromomethyl-4-bromobenzene 
• 24424-99-5 di-tert-butyl dicarbonate 
• 26177-44-6 4-bromobenzylamine hydrochloride 
• 3959-07-7 4-Bromobenzylamine 
• 1228692-99-6 C₂₃H₂₁BrF₁₇NO₃ 
• 107047-10-9 p-bromobenzylazide 
• 153171-22-3 2-(4-bromobenzyl)-1H-isoindole-1,3(2H)-dione 
• 1145-80-8 N-(benzyloxycarbonyl)-L-serine 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 4248-19-5 tert-butyl carbazate 
• 1122-91-4 4-bromo-benzaldehyde 

Downstream Products

• 258834-85-4 (1S)-1-[(N-tert-butoxycarbonylamino)methyl]phenyl-5-O-tert-butyldimethylsilyl-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol 
• 356067-03-3 N-Boc-4-aminobenzylprop-2-yn-1-(4'-tert-butylphenyl) ether 
• 312760-15-9 2-benzenesulfonylamino-3-({5-[4-(tert-butoxycarbonylamino-methyl)-phenyl]-thiophene-2-carbonyl}-amino)-propionic acid tert-butyl ester 
• 625116-32-7 [4-(1-ethoxy-vinyl)-benzyl]-carbamic acid tert-butyl ester 
• 935528-04-4 (4-trimethylsilylprop-1-ynylbenzyl)carbamic acid tert-butyl ester 
• 680190-95-8 (4-trimethylsilylethyn-1-ylbenzyl)carbamic acid tert-butyl ester 
• 935528-07-7 (4-ethynylphenyl)methanamine monohydrochloride 
• 625116-33-8 (4-azidoacetyl-benzyl)-carbamic acid tert-butyl ester 
• 625116-14-5 6-[5-(4-aminomethyl-phenyl)-oxazol-2-ylamino]-1-methyl-1H-indole-3-carbonitrile 

Relevant articles and documents

Synthesis and structure activity relationship of the first class of LXR inverse agonists

Liver X Receptors (LXRs) are members of the nuclear receptor family, and they play significant role in lipid and cholesterol metabolism. Moreover, they are key regulators of several inflammatory pathways. Pharmacological modulation of LXRs holds great pot

Small molecule compound based on EZH2 protein degradation, and application thereof

The invention discloses a series of small molecule compounds capable of selectively degrading EZH2 protein, and application thereof. The compounds can be prepared into proper pharmaceutical dosage forms for EZH2-mediated related tumor treatment.

COMPOUNDS AND USES THEREOF

The present disclosure features compounds useful for the treatment of BAF complex-related disorders.